Ethyl 7-bromoheptanoate

We are Ethyl 7-bromoheptanoate CAS:29823-18-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  Ethyl 7-bromoheptanoate
CAS.NO:29823-18-5
Molecular Formula: ：C9H17BrO2
Molecular Weight:237.13400

Synonyms:
ethyl-4-bromoheptanoate
ethyl 7-bromanylheptanoate
Ethyl 7-BroMoheptanoate
OOBFNDGMAGSNKA-UHFFFAOYSA
7-Bromoheptanoic Acid Ethyl Ester
BrCH2(CH2)5CO2Et
ethyl 7-bromo-heptanoate
7-Brom-heptansaeure-aethylester

Physical and Chemical Properties:
Density: 1.217 g / mL at 25 ° C (lit.)
Boiling point: 112 ° C5 mm Hg (lit.)
Melting point: 29 ° C (lit.)
Flash point:> 230 ° F
Refractive index: n20 / D 1.459 (lit.)

Specification:
Appearance:White  powder
Purity:≥99.0%
Moisture Content: <0.25%
Impurity: <0.3%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.

Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.400-98-6 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.5794-88-7 Since first being reported in the city of Wuhan, where it is believed to have originated at a seafood market, the virus has not provoked unusual symptoms in people who have been diagnosed.100-36-7 Since first being reported in the city of Wuhan, where it is believed to have originated at a seafood market, the virus has not provoked unusual symptoms in people who have been diagnosed.Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.